Home » Stocks » Cantel Medical

Cantel Medical Corporation (CMD)

Stock Price: $52.07 USD 0.25 (0.48%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 2.20B
Revenue (ttm) 1.02B
Net Income (ttm) 13.71M
Shares Out 42.16M
EPS (ttm) 0.32
PE Ratio 162.72
Forward PE 43.48
Dividend $0.21
Dividend Yield 0.40%

Stock Quote

Trading Day Oct 23, 2020
Last Price $52.07
Previous Close $51.82
Change ($) 0.25
Change (%) 0.48%
Day's Open 52.58
Day's Range 51.25 - 52.87
Day's Volume 478,022
52-Week Range 20.81 - 79.50

More Stats

Market Cap 2.20B
Enterprise Value 3.03B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 42.16M
Float 34.93M
EPS (basic) 0.32
EPS (diluted) 0.32
FCF / Share 2.45
Dividend $0.21
Dividend Yield 0.40%
Earnings Yield 0.61%
FCF Yield 4.69%
Payout Ratio 32.80%
Shares Short 3.23M
Short Ratio 7.14
Short % of Float 9.24%
Beta 1.38
PE Ratio 162.72
Forward PE 43.48
P/FCF Ratio 21.30
PS Ratio 2.16
PB Ratio 2.99
Revenue 1.02B
Operating Income 48.31M
Net Income 13.71M
Free Cash Flow 103.06M
Net Cash -832.12M
Net Cash / Share -19.74
Gross Margin 45.53%
Operating Margin 4.75%
Profit Margin 1.30%
FCF Margin 10.14%
ROA 4.02%
ROE 1.97%
ROIC 3.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 3
Overweight 1
Hold 2
Underweight 1
Sell 0

Analyst Consensus: Overweight

Price Target

$64.75*
(24.35% upside)
Low
52.0
Current: $52.07
High
72.0
Target: 64.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue1,016918872770665565489425386322
Revenue Growth10.66%5.3%13.21%15.86%17.65%15.6%14.99%9.97%20.16%-
Gross Profit436427414367309253213183164123
Operating Income48.3183.5212211097.2580.7670.9363.1951.5231.34
Net Income13.7155.0491.0471.3859.9547.9543.2739.2431.3420.43
Shares Outstanding42.1541.7741.7141.7241.7041.5541.3841.0840.5038.72
Earnings Per Share0.321.322.181.711.441.151.040.950.770.52
EPS Growth-75.76%-39.45%27.49%18.75%25.22%10.58%9.47%23.38%48.08%-
Dividend Per Share0.110.200.170.140.120.100.090.070.060.05
Dividend Growth-47.5%17.65%21.43%16.67%20%11.11%21.62%19.35%16.98%-
Operating Cash Flow13766.9312610880.2759.0764.2751.4950.5828.20
Capital Expenditures-33.80-95.44-37.70-27.02-18.79-12.74-13.53-6.71-5.49-5.76
Free Cash Flow103-28.5188.2181.1861.4846.3450.7544.7845.0922.44
Cash & Equivalents27844.5494.1036.5828.3731.7231.7834.0830.1918.41
Total Debt1,11023119712611678.5080.5095.0090.0024.00
Net Cash / Debt-832-186-103-89.42-87.63-46.78-48.72-60.92-59.81-5.59
Assets2,0721,070964786695584536488435321
Liabilities1,34240935526224017717116715987.13
Book Value730662609524454407365321276234
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cantel Medical Corporation
Country United States
Employees 3,669
CEO George L. Fotiades

Stock Information

Ticker Symbol CMD
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: CMD

Description

Cantel Medical provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.